| Dr John A Garcia, MD | |
|
1631 Hospital Dr, Suite 200, Santa Fe, NM 87505-4728 | |
| (505) 424-0200 | |
| (505) 424-6608 |
| Full Name | Dr John A Garcia |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 26 Years |
| Location | 1631 Hospital Dr, Santa Fe, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417950460 | NPI | - | NPPES |
| 7135504 | Other | AETNA | |
| 9274 | Other | EXCLUSIVE CHOICE | |
| 2305584 | Other | UHC | |
| 43511 | Other | HEALTHCARE USA | |
| 5729197 | Other | CIGNA | |
| 179426 | Other | BLUE CROSS BLUE SHIELD | |
| 351240001 | Other | CIGNA DMERC | |
| 561510 | Other | HEALTHLINK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 2003001211 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Klarus Home Care, Llc | Albuquerque, NM | Home health agency |
| Kindred At Home | Albuquerque, NM | Home health agency |
| Los Alamos Visiting Nurse Service, Inc | Los alamos, NM | Home health agency |
| Compassus Home Health Albuquerque Nm | Albuquerque, NM | Home health agency |
| Presbyterian Santa Fe Medical Center | Santa fe, NM | Hospital |
| Presbyterian Hospital | Albuquerque, NM | Hospital |
| Christus St Vincent Regional Medical Center | Santa fe, NM | Hospital |
| Holy Cross Hospital A Div Of Taos Health Systems | Taos, NM | Hospital |
| Los Alamos Medical Center | Los alamos, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Espanola Sports Medicine Pa | 2163691411 | 64 |
| Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children's Center.
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.
Researchers calculated the costs of management of low back pain and found that an integrated and step-wise approach within a multidisciplinary setting forms a better use of the available resources. The study is published in the September issue of Pain Practice.
› Verified 5 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children's Center.
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.
Researchers calculated the costs of management of low back pain and found that an integrated and step-wise approach within a multidisciplinary setting forms a better use of the available resources. The study is published in the September issue of Pain Practice.
› Verified 5 days ago
| Entity Name | Los Alamos Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750330510 PECOS PAC ID: 4587661541 Enrollment ID: O20061104000041 |
News Archive
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children's Center.
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.
Researchers calculated the costs of management of low back pain and found that an integrated and step-wise approach within a multidisciplinary setting forms a better use of the available resources. The study is published in the September issue of Pain Practice.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John A Garcia, MD 1631 Hospital Dr, Suite 200, Santa Fe, NM 87505-4728 Ph: (505) 424-0200 | Dr John A Garcia, MD 1631 Hospital Dr, Suite 200, Santa Fe, NM 87505-4728 Ph: (505) 424-0200 |
News Archive
Traditionally viewed as supporting actors, cells known as glia may be essential for the normal development of nerve cells responsible for hearing and balance, according to new University of Utah research. The study is reported in the January 6, 2005 issue of Neuron and is co-authored by scientists at the University of Washington.
Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children's Center.
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.
Shire plc, the global specialty biopharmaceutical company, today presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease. The data were presented in an oral presentation at the Lysosomal Disease Network (LDN) World Symposium in Miami, Florida.
Researchers calculated the costs of management of low back pain and found that an integrated and step-wise approach within a multidisciplinary setting forms a better use of the available resources. The study is published in the September issue of Pain Practice.
› Verified 5 days ago
Jan V.t. Bear, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1631 Hospital Dr, Suite 200, Santa Fe, NM 87505 Phone: 505-424-0200 Fax: 505-424-6608 | |
Dr. Jennifer Kathleen Wagner, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2968 Rodeo Park Dr W Ste 150, Santa Fe, NM 87505 Phone: 505-913-5227 | |
Robin Sann Gossum, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1631 Hospital Dr, Suite 200, Santa Fe, NM 87505 Phone: 505-424-0200 Fax: 505-424-6608 | |
Samuel Chun, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1631 Hospital Dr, Suite 200, Santa Fe, NM 87505 Phone: 505-424-0200 Fax: 505-424-6608 | |
Dr. David W Caldwell, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1841 Sun Mountain Dr, Santa Fe, NM 87505 Phone: 505-986-9665 | |
William K Jones, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2801 Rodeo Rd, Suite B13, Santa Fe, NM 87507 Phone: 505-983-6226 |